A detailed history of Northeast Financial Consultants Inc transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Northeast Financial Consultants Inc holds 6,568 shares of TMO stock, worth $3.44 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
6,568
Previous 6,559 0.14%
Holding current value
$3.44 Million
Previous $3.63 Million 11.99%
% of portfolio
0.18%
Previous 0.17%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$531.86 - $624.21 $4,786 - $5,617
9 Added 0.14%
6,568 $4.06 Million
Q2 2024

Aug 15, 2024

BUY
$541.52 - $599.02 $20,036 - $22,163
37 Added 0.57%
6,559 $3.63 Million
Q1 2024

May 15, 2024

SELL
$528.82 - $599.43 $26,441 - $29,971
-50 Reduced 0.76%
6,522 $3.79 Million
Q4 2023

Feb 14, 2024

BUY
$431.41 - $532.94 $90,596 - $111,917
210 Added 3.3%
6,572 $3.49 Million
Q1 2023

May 15, 2023

SELL
$535.0 - $604.82 $96,835 - $109,472
-181 Reduced 2.77%
6,362 $3.67 Million
Q2 2022

Aug 12, 2022

SELL
$500.9 - $612.21 $24,544 - $29,998
-49 Reduced 0.74%
6,543 $3.56 Million
Q1 2022

May 12, 2022

BUY
$524.0 - $644.92 $25,676 - $31,601
49 Added 0.75%
6,592 $3.89 Million
Q4 2021

Feb 11, 2022

SELL
$569.0 - $667.24 $12,518 - $14,679
-22 Reduced 0.34%
6,543 $4.37 Million
Q3 2021

Nov 15, 2021

SELL
$509.53 - $609.78 $11,719 - $14,024
-23 Reduced 0.35%
6,565 $3.75 Million
Q2 2021

Aug 16, 2021

BUY
$441.0 - $508.24 $5,292 - $6,098
12 Added 0.18%
6,588 $3.32 Million
Q1 2021

May 13, 2021

BUY
$439.85 - $518.83 $14,075 - $16,602
32 Added 0.49%
6,576 $3 Million
Q4 2020

Feb 12, 2021

SELL
$435.06 - $527.66 $110,940 - $134,553
-255 Reduced 3.75%
6,544 $3.05 Million
Q3 2020

Oct 29, 2020

SELL
$359.77 - $441.52 $2,518 - $3,090
-7 Reduced 0.1%
6,799 $3 Million
Q2 2020

Jul 30, 2020

SELL
$275.2 - $362.34 $4,678 - $6,159
-17 Reduced 0.25%
6,806 $2.47 Million
Q1 2020

May 13, 2020

BUY
$255.3 - $340.05 $1,021 - $1,360
4 Added 0.06%
6,823 $1.94 Million
Q4 2019

Feb 14, 2020

SELL
$271.93 - $328.04 $1.45 Million - $1.74 Million
-5,315 Reduced 43.8%
6,819 $2.22 Million
Q3 2019

Nov 13, 2019

BUY
$268.46 - $305.43 $17,449 - $19,852
65 Added 0.54%
12,134 $3.53 Million
Q2 2019

Aug 09, 2019

BUY
$257.51 - $295.55 $18,025 - $20,688
70 Added 0.58%
12,069 $3.54 Million
Q1 2019

May 14, 2019

SELL
$212.17 - $273.72 $164,219 - $211,859
-774 Reduced 6.06%
11,999 $3.28 Million
Q4 2018

Feb 12, 2019

BUY
$208.47 - $251.98 $2.45 Million - $2.97 Million
11,773 Added 1177.3%
12,773 $2.86 Million
Q1 2018

Apr 19, 2018

SELL
$192.98 - $224.11 $96,490 - $112,055
-500 Reduced 33.33%
1,000 $206,000
Q4 2017

Feb 14, 2018

SELL
$182.03 - $200.37 $728,120 - $801,480
-4,000 Reduced 72.73%
1,500 $284,000
Q3 2017

Nov 13, 2017

BUY
$171.74 - $194.04 $944,570 - $1.07 Million
5,500
5,500 $1.04 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $205B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Northeast Financial Consultants Inc Portfolio

Follow Northeast Financial Consultants Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northeast Financial Consultants Inc, based on Form 13F filings with the SEC.

News

Stay updated on Northeast Financial Consultants Inc with notifications on news.